We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 140 start-ups with an aggregate funding of $5.4b. The average funding per company in this subset is $78.9m.
Last update to the database: Feb 18, 2025. See changelog.
15
Funding Rounds
$140.4m
Money raised
Synthace is a software company based out of London, UK, building automation software that gives biologists the ability to control and analyze the performance of lab hardware.
1
Funding Rounds
$25.3m
Money raised
Leo Cancer Care is a company developing upright radiotherapy solutions.
2
Funding Rounds
$16.8m
Money raised
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
6
Funding Rounds
$86.6m
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
3
Funding Rounds
$143.4m
Money raised
An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.
2
Funding Rounds
$4.5m
Money raised
Cellink AB is a biotechnology research company based in Gothenburg.
10
Funding Rounds
$187.8m
Money raised
Causaly is a biomedical research discovery tool founded in 2018 by Yiannis Kiachopoulos.
Dharmacon, Inc. is a Lafayette, Colorado-based company founded in 1995.
5
Funding Rounds
$82.8m
Money raised
Peptome is a London-based protein physics intelligence company founded in 2016 by Kamil Tamiola and Matt Heberling. It utilizes artificial intelligence for computers to process all information about protein data in the same efficient way that scientists do.
7
Funding Rounds
$31.4m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
2
Funding Rounds
$645.0k
Money raised
CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
5
Funding Rounds
$30.9m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
10
Funding Rounds
$62.4m
Money raised
A software solutions company providing bioinformatics solutions to life science and other sector
4
Funding Rounds
$124.1m
Money raised
Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.
6
Funding Rounds
$133.6m
Money raised
Intelligent, distributed & reproducible big data & genomics analysis at scale. Zero onboarding. Zero config.
1
Funding Rounds
$4.7m
Money raised
Asimov is a startup that programs living cells with genetic circuits.
6
Funding Rounds
$62.1m
Money raised
Crown bioscience is a company that is focused on research, drug discovery and development for the treatment of cancer and diabetes.
2
Funding Rounds
$2.6m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
1
Funding Rounds
Isomerase is a Cambridge based microbial natural products drug discovery and development CRO and synthetic biology, fermentation and chemistry service provider
3
Funding Rounds
$13.2m
Money raised
Biosceptre is a Cambridge, Cambridgeshire-based company developing diagnostic tools and biomarkers.
2
Funding Rounds
$155.0m
Money raised
Digital health platform for predictive care and research.
3
Funding Rounds
$126.0m
Money raised
Health technology startup that creates personalized behavioral medicine programs
5
Funding Rounds
$50.1m
Money raised
Tatum is a blockchain developer platform. It offers products such as NFT plug-ins for Wordpress, software development kits for over 40 protocols and an API that enables NFT minting across various blockchains.
2
Funding Rounds
$10.0m
Money raised
Macomics is an Edinburgh-based immuno-oncology company.
4
Funding Rounds
$241.9m
Money raised
Asklepios Biopharmaceutical is a company in North Carolina.
4
Funding Rounds
$179.4m
Money raised
Kymab is a biopharmecutical company developing human antibody based therapies founded in 2010.
1
Funding Rounds
Oxford Cancer Biomarkers is an Oxford-based biomarker company commercializing biomarker tests for colorectal cancer testing.
4
Funding Rounds
$420.2m
Money raised
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells
5
Funding Rounds
$302.6m
Money raised
Oral antifungal therapy developer to treat life-threatening rare fungal infections
2
Funding Rounds
$44.0m
Money raised
BC Platforms provide data management systems for clinical and genomic research, pharmacogenomics research, preventive and personalized medicine, and biobanking.
4
Funding Rounds
$76.8m
Money raised
Provider of SITESEEKER platform for discovering new drugs.
4
Funding Rounds
$18.4m
Money raised
Cell analysis technology provider.
1
Funding Rounds
$1.2m
Money raised
Brainvectis is a biotechnology company developing treatments for neurodegenerative diseases through restoring cholesterol metabolism in the brain.
3
Funding Rounds
$45.5m
Money raised
A company offering a medication management platform that gives insight into patient behavior.
2
Funding Rounds
$6.9m
Money raised
C4X Discovery is a company that is developing a virtual reality tool, 4Sight, to help chemists discover new drugs by visualizing the structure of complex molecules.
7
Funding Rounds
$25.9m
Money raised
Oxford BioTherapeutics is a clinical-stage oncology company based in Oxford, UK, Morristown, and San Jose, USA. The company develops immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies.
7
Funding Rounds
$90.2m
Money raised
EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.
5
Funding Rounds
$111.1m
Money raised
Medication and supplements provider for men’s health conditions.
3
Funding Rounds
$77.0m
Money raised
PetMedix is a veterinary therapeutics biotechnology company based in Cambridge, UK. working to develop precision therapeutics to improve the health and welfare of pets.
3
Funding Rounds
$41.0m
Money raised
We're a next gen CRO running end-to-end clinical trials for health and biotech pioneers. From trial design to recruitment and delivery, we accelerate trials.
2
Funding Rounds
$1.4m
Money raised
Almac is a biomedical services company based in the UK founded in 1968 by Allen McClay.
3
Funding Rounds
$115.0m
Money raised
Platform for AI-driven drug discovery in clinical-stage development.
4
Funding Rounds
$101.6m
Money raised
Small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer
2
Funding Rounds
$20.0m
Money raised
A company that provides services and technologies for the development and commercialization of biopharmaceutical products
4
Funding Rounds
$166.8m
Money raised
Crescendo Biologics is an immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics.
4
Funding Rounds
$345.0m
Money raised
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
4
Funding Rounds
$53.0m
Money raised
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.
1
Funding Rounds
$40.6m
Money raised
Therapies designed to achieve long-term disease remission with less frequent doses.
6
Funding Rounds
$29.7m
Money raised
Actimed Therapeutics Ltd is a cachexia Treatments founded in 2016.
4
Funding Rounds
$49.4m
Money raised
Ochre Bio is a biotechnology platform focused on rejuvenating transplant livers founded in 2019 by Jack O'Meara.
1
Funding Rounds
Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.
1
Funding Rounds
$45.5m
Money raised
Silence Therapeutics is a London-based company founded in 1999.
4
Funding Rounds
$58.3m
Money raised
Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.
2
Funding Rounds
$160.0m
Money raised
Beckley Psytech is a psychedelic Compounds founded in 2019 by Lady Amanda Feilding.
4
Funding Rounds
$148.0m
Money raised
e-Therapeutics is an In-Silico Drug Discovery founded in 2003.
1
Funding Rounds
$34.2m
Money raised
Avacta Group PLC is a drug Development Platform, Engineered Antibodies founded in 2012.
2
Funding Rounds
$5.4m
Money raised
Kinomica is a Cheshire, United Kingdom-based proteomic-data science and diagnostics company that specializes in cell-signaling.
2
Funding Rounds
$2.8m
Money raised
Platform to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.
1
Funding Rounds
A pharmaceutical company specializing in drug candidates used for in out-patient and hospital-based sedation
1
Funding Rounds
$718.0k
Money raised
A company offering medicinal chemistry and computational chemistry services for drug dicovery
1
Funding Rounds
$86.4m
Money raised
Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics.
2
Funding Rounds
$15.2m
Money raised
Personalized cancer treatment company
4
Funding Rounds
SiSaf is the first company to create a Bio-Courier platform technology.
1
Funding Rounds
$4.5m
Money raised
A cancer diagnostiics company that uses blood tests to guide cancer therapy
1
Funding Rounds
$550.0m
Money raised
Catalent America is a company that provides superior drug delivery technologies.
3
Funding Rounds
$40.6m
Money raised
Osler Diagnostics is a biosensor and medical device company.
1
Funding Rounds
$1.2m
Money raised
ValiRx PLC. is a Cambridge, Massachusetts-based healthcare accelerator working to develop new medicines and technologies founded in 2000.
2
Funding Rounds
$3.2m
Money raised
Online platform for identifying, interacting, and booking e-consultations with medical specialists in private healthcare.
Enter your email and get access to 71,000 + technology companies you can partner with.